Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal CancerRalf‐Dieter Hofheinz, G. Stehle, P. Tanswell et al.|Oncology Research and Treatment|2003Cited by 364